GLS and neoplasm: Specifically, the anti-tumor effect of CB-839 is mainly through the following two mechanisms: firstly, GLS inhibition disrupts glutamate metabolism, leading to the accumulation of glutamate in tumor cells; secondly, it causes metabolic disruption, causing tumor cells to lose their ability to synthesize α-ketoglutarate, which is essential for their rapid proliferation and survival.